Obesity Management Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rise in Prevalence of Obesity Worldwide
   3. Market Restraints
      1. Lack of Insurance Coverage
      2. Stigma & Social Perception
   4. Market Opportunities
      1. Escalating Prevalence of Obesity Among Children and Adolescents
   5. Market Trends
      1. Rise of Digital Therapeutics
      2. Shift Towards Personalized Medicines
5. MARKET SEGMENTATION
   1. By Drug Type
      1. Bupropion and Naltrexone
      2. Orlistat
      3. Lorcaserin
      4. Phentermine and Topiramate
      5. Liraglutide
   2. By Surgery Type
      1. Gastric Bypass Surgery
      2. Adjustable Gastric Banding Surgery
      3. Gastric Sleeve Surgery
      4. Duodenal Switch Surgery
      5. Others
   3. By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. E-commerce
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. AstraZeneca
      2. Bausch Health Companies Inc.
      3. Currax Pharmaceuticals LLC
      4. Cheplapharm Arzneimittel GmbH
      5. F. Hoffmann-La Roche Ltd.
      6. GlaxoSmithKline Plc
      7. Novo Nordisk A/S
      8. Pfizer, Inc.
      9. Takeda Pharmaceuticals, Inc.
      10. VIVUS, Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global obesity managementmarket?

The global market of obesity management is projected to reach USD 3479.09Mn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global obesity managementmarket?

The global obesity management market has an estimated annual growth rate of 5.2% .

Q.3. What are the recent trends of obesity managementmarket?

Rise of digital therapeutics and shift towards personalized medicines are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in obesity management?

The major companies profiled in this report include AstraZeneca, Bausch Health Companies Inc.,Currax Pharmaceuticals LLC, Cheplapharm Arzneimittel GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Novo Nordisk A/S, Pfizer, Inc., Takeda Pharmaceuticals, Inc., VIVUS, Inc., among others.

Q.5. Which region is estimated to held highest CAGR inobesity managementmarket?

North America is estimated to hold biggest share in the market for obesity management.